178 views
Source: GuocoLand

GuocoLand profit ‘more than doubles’ to $392.7m in 2022

This reflects a 132% growth during the period. 

GuocoLand reported its profit attributable to equity holders ‘more than doubled” after it grew 132% to $392.7m in the full year ended June 2022. 

Over the same period, its revenue rose 13% to $965.5m, which was supported by the Group’s property development and property investment business. 

Its property development and property investment business saw a 12% and 10% growth, respectively. 

Read more: Tradition meets modernity in futureproofing hybrid offices 

“Our strategy to diversify the Group’s profit sources through growing our investment business in addition to development business is delivering results,” Cheng Hsing Yao, CEO of GuocoLand Group, said. 

“As Guoco Midtown completes in stages, it will further boost our recurrent income.”

Across its segments, GuocoLand’s Singapore operations accounted for more than 70% of its revenue. 

Moreover, GuocoLand China’s revenue stood at $105.4m, mainly due to the sale of two low-rise office blocks in Guoco Changfeng City in Shanghai; whilst GuocoLand Malaysia’s revenue amounted to $128.3m. 

 

Follow the link for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Top News

Singapore researchers develop rapid gut biomarker nanosensor
The optical platform can detect indole-3-propionic acid within minutes.
Tuas pharmaceutical facility put up for sale at $90m
The nine-hectare site has about 535,000 sq ft of untapped gross floor area for potential expansion.
Commercial Property
Brand New Land launches four freehold terrace homes in District 11
Prices at the Solstice development start from $9.38m, with completion targeted for the second half of 2027.
Residential Property